Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
Submitted by
admin
on December 12, 2017 - 10:06am
Source:
Fierce Pharma
News Tags:
ASH17
JNJ
Darzalex
Multiple Myeloma
Janssen
Headline:
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
Do Not Allow Advertisers to Use My Personal information
